Cambridge Healthtech Institute’s 12th Annual

Enrollment Planning and Patient Recruitment

Strategic Enrollment Planning, Data-Driven Recruitment and Forecasting, and Central Campaign Management

February 19-20, 2019

 

Patient recruitment and up-front enrollment planning are critical to drug development programs. Patient recruitment if not adequately planned for can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for your analysis and subsequent filings. In order to optimize both you have to have a plan and effectively leverage analytics and technology without losing site of the participant’s user experience. CHI’s 12th Annual “Enrollment Planning and Patient Recruitment” will cover the topics one should consider when drafting and strategically implementing a patient recruitment plan for a clinical development program.

Final Agenda

Stay on and attend Part 2 (Wed-Thurs): Patient Engagement, Enrollment and Retention through Communities and Technology

Monday, February 18

9:00 am 7:15 pm Registration Open

2:005:00 pm User Group Meetings

Shared Investigator Platform User Forum


Trifecta Annual User Group Forum

5:006:15 pm Pre-Conference Plenary Keynote Panel & Participant Engagement Award

6:157:15 pm SCOPE’s Kick-off Networking Happy Hour Hosted by CHI (Sponsorship Opportunities Available)

7:15 pm Close of Day

Tuesday, February 19

7:15 am Registration Open and Morning Coffee

8:15 Opening Plenary Keynotes

9:35 Grand Opening Coffee Break in the Exhibit Hall

DIGITIZING TRIALS AND PATIENT RECRUITMENT TO IMPROVE PATIENT EXPERIENCE AND RETENTION

10:35 Chairperson’s Remarks

Chairperson to be Announced, WIRB Copernicus Group

10:40 CO-PRESENTATION: Translating Patient Insight and Patient Experience into Clinical Development Deliverables

Kellar-Wood_HelenHelen Kellar-Wood, PhD, Associate Director, Oncology and Immunoscience Lead, Diversity & Patient Engagement, Bristol-Myers Squibb


Murray_MaryMary Murray, Associate Director, Oncology Lead, Diversity & Patient Engagement, Bristol-Myers Squibb

Patient Engagement can be viewed in a structure, process and outcomes framework (known as a quality systems framework). Taking this approach can help clinical development teams design trials and create deliverables that meet industry goals while aligning with patients’ needs. We know that patient engagement frequently occurs at specific points in the clinical development process; however, in this presentation we will explore how we can change this paradigm by leveraging a quality systems framework to embedding the patient’s viewpoint for better outcomes.

11:10 The Changing Face of Digital Patient Recruitment: Better Data-Driven Decisions

McCormick_AmyAmy McCormick, Innovation Lead, Patient Experience and Design Innovation, Eli Lilly & Co.

This talk will focus on new approaches to digital patient recruitment. It will focus on real-world examples using data-driven decisions to adapt recruitment and retention strategies. Examples on how to provide patients and caregivers with useful information to help guide them through their journey.


11:40 CO-PRESENTATION: Digitizing a Patient-Focused Clinical Trial Experience

Yates_StephenStephen Yates, Clinical Program Director, UCB


Erb_KelleyKelley Erb, Lead, TransCelerate’s Novel Digital Endpoints; Director, Digital Medicine, Pfizer

During this interactive session, leaders from TransCelerate Member Companies will candidly share their experiences collaborating to create solutions that will bring about innovative change, and address some of our industry’s greatest challenges. They will discuss the four key initiatives that, using innovative digital efforts, have the potential to transform clinical trials. The audience will learn how the use of patient technologies, eConsent, eLabels, and electronic health records (EHRs) can advance clinical research and create the patient experience of the future.

12:10 pm Presentation to be Announced

12:40 Transition to Lunch

12:45 LUNCHEON PRESENTATION: Bringing the Trial to the Patient: Virtual Trials and the Promise of Patient Engagement

Rose_Josh_RCT Josh Rose, Vice President, Global Head, Strategy, Research and Development Solutions, IQVIA

The shift to virtual trials is upon us. With it comes a myriad of benefits to both the patient and sponsor. This presentation will share how early adopter studies are delivering more rapid patient enrollment, higher retention, better data quality and overall faster cycle times.


1:25 Coffee and Dessert Break in the Exhibit Hall

ENGAGEMENT, RECRUITMENT AND RETENTION LESSONS LEARNED FROM COMPLEX, GLOBAL & RARE DISEASE STUDIES

2:05 Chairperson’s Remarks

Melanie Goodwin, Director, Patient Recruitment Programs, Clinical Development & Operations, Global Product Development, Pfizer

2:10 Lessons Learned from a Successful Phase 3 Program in Japan: Culture, Engagement, Recruitment and Retention

Dubourg_Julie Julie Dubourg, MD, Medical Director, Clinical Development, Poxel

This talk will focus on patient recruitment and retention in the settings of a first-in-class registration program in Japan. There are many factors to consider when planning a registration program in Japan from a European biotech company perspective and efficient strategies will be presented.


2:40 Can Historical Data and Analytics be Used for Recruitment Planning in Rare Diseases?

Dimitrova_Angela Angela Dimitrova, MD, Senior Director, Feasibility Group Lead Rare Diseases, Study Optimization, Pfizer

Rare disease studies are more difficult to enroll because of the much smaller patient pools. Planning enrollment durations for rare diseases is also more challenging and complicated due to rarity of data. In this presentation we will review the opportunities to use evidence-based and data-driven approaches to better plan enrollment in rare diseases.

3:10 CO-PRESENTATION: The Digital Clinical Trial Recruitment Landscape: Insights and a Fireside Chat

Gwee_Shwen Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development, Novartis


Greene_JeffJeff Greene, Vice President, Digital Strategy & Insights, Decision Resources Group

More than ever, patients feel empowered to play an active role in their health decisions. That extends to their participation in clinical trials - and digital advances have made it a lot easier. Over 30% of U.S. patients have expressed interest in going online to find clinical trials. Among rare disease patients willing to participate in a clinical trial, nearly 60% have accessed prescription drug information from social media. But many pharma companies struggle to integrate digital solutions into their clinical trial recruitment strategies. Come join this interactive session where we’ll highlight DRG Digital’s latest study, The Digital Clinical Trial Recruitment Landscape. This session will also end with a brief fireside chat that discusses what clinical can learn from marketing to develop better digital strategies that enhance and accelerate trial recruitment.

BBK_Worldwide_tagline 3:40 Presentation to be Announced

BREAKOUT DISCUSSION GROUPS

4:10 Find Your Table and Meet Your Moderator

4:15 Interactive Breakout Discussion Groups

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions. To get the most out of this interactive session and format, please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and most importantly, participate in active idea sharing.

5:00 Welcome Reception in the Exhibit Hall

6:30 Close of Day

Wednesday, February 20

7:15 am Registration Open

7:45 BREAKFAST PRESENTATION to be Announced

8:15 Session Break

INNOVATIVE DIGITAL APPROACHES TO PATIENT IDENTIFICATION AND ENGAGEMENT

8:20 Chairperson’s Remarks

Neil Weisman, Executive Vice President, Continuum Clinical

8:25 Active Patient Identification: The Power of Patients and the Role of Grit in Pre-Determining Retention

Becker_Lynne Lynne Becker, Senior Data Analyst, Enterprise Intelligence & Data Solutions (EIDS) Program Management Office (PMO), Deputy Assistant Director Information Operations, Defense Health Agency (DHA)

Patient engagement implies a variety of methods that is differentiated amongst organizations and its application is becoming confused, perhaps diluting its intent. Patients are being bombarded with a plethora of technology, social media, wearables and now concierge services to become “engaged”; but engagement for a hospital administrator differs from a clinical trial sponsor, which differs from the clinician and even further differs from the actual patient. Our position is to pre-identify the grittiness of a clinical trial candidate before they are overwhelmed with these services. Then appropropriately apply your engagement resources in a more efficient manner to improve the clinical trial’s return on investment.

8:55 A New Ecosystem for Clinical Trials Recruitment: Go Where the Patients Are

Jadhav_Pravin Pravin Jadhav, PhD, Senior Director, Corporate Projects, R&D Innovation, Otsuka Pharmaceutical Development and Commercialization (OPDC)

Almost two-thirds of clinical sites do not meet patient recruitment targets. There have been a number of approaches explored to boost clinical trial recruitment with some mixed success. While there are tools with promising visuals by leveraging big data analytics, most tools do not provide any actionable insight for study teams to implement in areas “where the patients are.” An example of leveraging smart data analytics combining real world data, internal clinical operations data and publicly available resources will be discussed that supported development of a novel and actionable targeted recruitment approach.

9:25 CO-PRESENTATION: Creating a Connected Patient Engagement Platform through Innovative Digital Approaches

Brehm_Carolyn Carolyn Brehm, Associate Director, BMS Study Connect Business Lead, Bristol-Myers Squibb


Das_Mano Mano Das, IT Business Partner, Clinical Patient and Site Operations, Bristol-Myers Squibb

Through global expansion and innovative digital approaches, BMS has created an industry-leading patient engagement platform dedicated to increasing clinical trial awareness, participation and engagement. BMS Study Connect is a comprehensive clinical trial resource for patients and caregivers to learn about and find clinical trials, and connect with others. The platform delivers an experience that empowers patients, provides transparency, and supports patients and caregivers before, during and after a clinical trial.

9:55 Patient Engagement: Treating Patients Like Customers

Clarke_Ivor_RCT Ivor Clarke, CEO, SubjectWell

You’re a consumer. As such, what do you look for when choosing a product or service to meet your needs? Price? Quality? Convenience? Customer Service? All of the above? Patients are consumers too and they, just like you, are accustomed to being able to engage providers with ease. In this session, get insights into how other industries inform and engage consumers and explore how you can apply those same techniques to your next study.

10:25 Coffee Break in the Exhibit Hall

11:20 Chairperson’s Remarks

Chairperson to be Announced, Seeker Health

11:25 The Clinical Research “Highway”: A Map for Partnering with Patients

Dietrich_Julie Julie Dietrich, Director, Center for Design & Analysis, Amgen

How can biopharma organizations collaborate effectively with patients throughout clinical program and study design and planning? This interactive presentation will lay out a complete partnership pathway from study concept development through study results readout, based on case studies and learnings.


11:45 How eConsent Helped Roche Enroll and Retain Patients for a Complex Oncology Trial

Danner_Olaf Olaf Danner, Global Studies Manager, Roche

This session will tell the story of a recent multi-cohort oncology study conducted by Roche. Specifically, it will identify how and why Roche developed targeted education and videos for each oncology cohort group, using eConsent, and how that improved engagement, enrollment, and retention. The talk will share: How eConsent was deployed to address each cohort group; the process for identifying, developing, and implementing each educational video; the benefits of Roche’s approach and why patients better understood the risks and needs of the trial.

12:05 CASE STUDY: Building a Patient-Centric Platform for Improved Recruitment and Retention

Goodwin_Melanie Melanie Goodwin, Director, Patient Recruitment Programs, Clinical Development & Operations, Global Product Development, Pfizer

Communications and trial support of patients before, during, and after trial participation is challenging, yet will positively support enrollment and retention efforts of our clinical trials. And while we have ways to solve each of these, how do we make the process simple for our study volunteers? By building a single platform solution that will allow each study volunteer to obtain information and support based on their individual needs.

12:25 pm Transition to Lunch

12:30 BRIDGING LUNCHEON PRESENTATION: Leveraging Analytics and the Patient Voice to Optimize Patient Recruitment & Retention Campaigns

Loll_Robert Robert Loll, Senior Vice President, Business Development & Strategic Planning, Praxis Communications, LLC

As the world becomes more and more digital, it is important to tap into the endless amounts of data and conversations being shared on the Internet to glean patient insights and understanding. As we have lunch, we’ll explore case studies and discuss how our industry can utilize data and analytics to craft and optimize efficient and effective patient-centric enrollment campaigns.

1:10 Coffee and Dessert Break in the Exhibit Hall

2:10 Close of Conference

Stay on and attend Part 2 (Wed-Thurs): Patient Engagement, Enrollment and Retention through Communities and Technology

Register!

“SCOPE Featured Author”
Emmanuel Fombu, MD,
Director, Digital Health Solutions
Novartis


Signature Sponsors

IQVIA

Medidata


Premier Sponsors

Appian
Axiom

BBK-Worldwide

Bioclinica_new

ClinicalInk

Covance

DrugDev

ERT
Mendel Health
Oracle-Health-Sciences

PRA Health Sciences 
Saama-Technologies

Syneos Health

UBC_new

Veeva